What are the treatment guidelines for tetanus?

Treatment Guidelines for Tetanus

Immediate Management of Active Tetanus Infection

For patients with established tetanus infection, immediately administer human Tetanus Immune Globulin (TIG) at higher doses than prophylactic dosing, perform aggressive wound debridement, and initiate metronidazole as the preferred antimicrobial agent. 1

Critical First Steps

• Administer TIG promptly to neutralize circulating tetanospasmin toxin; prophylactic dosing is 250 units intramuscularly, but established tetanus requires higher doses 1
• Perform thorough surgical debridement of all necrotic tissue and wound cleaning to eliminate the anaerobic environment where Clostridium tetani produces toxin 1, 2, 3
• Initiate antimicrobial therapy with metronidazole as the preferred agent, or alternatively penicillin G, to eradicate C. tetani bacteria 1, 3
• Do NOT administer tetanus toxoid to patients with active tetanus infection, as it provides no therapeutic benefit for established disease 1

Supportive Care Requirements

• Implement early mechanical ventilation for any signs of respiratory compromise, as respiratory failure is a leading cause of death 1
• Monitor and manage autonomic instability aggressively, particularly during weeks 2-3 of illness, as this complication carries high mortality 1
• Control neuromuscular symptoms with benzodiazepines (diazepam), narcotics for analgesia, and neuromuscular blocking agents (pancuronium) as needed for severe spasms 4
• Watch for rhabdomyolysis secondary to severe muscle spasms 1
• Provide stress ulcer prophylaxis and deep vein thrombosis prevention 4

High-Risk Populations

• Elderly patients (>60 years) require particularly aggressive management as they have substantially lower protective antibody levels (only 21% of women and 45% of men >70 years have protective levels) and represent 38% of all tetanus cases despite being a smaller population segment 2
• Immunocompromised patients may require additional TIG doses regardless of vaccination history 1
• The case fatality rate remains 18-21% even with modern intensive care, necessitating early aggressive intervention 1, 2

---

Wound Management and Tetanus Prophylaxis

For tetanus-prone wounds (contaminated, puncture wounds, or wounds >6 hours old), administer tetanus toxoid if the last dose was >5 years ago; for clean minor wounds, give toxoid only if >10 years since last dose. 5, 1, 2

Wound Classification and Care

• Tetanus-prone wounds include: puncture wounds, wounds contaminated with dirt/feces/saliva, wounds with devitalized tissue, wounds >6 hours old, and wounds from crush injuries or burns 2
• Perform thorough wound cleaning and debridement as the critical first step, removing all debris that could harbor C. tetani spores 2
• Surgical debridement of necrotic tissue is essential for wounds creating anaerobic conditions favorable for bacterial growth 2

Tetanus Toxoid Administration Algorithm

For clean, minor wounds:

• Give tetanus toxoid booster if >10 years since last dose 5, 1, 2
• No TIG needed if patient has completed primary series 2

For tetanus-prone/contaminated wounds:

• Give tetanus toxoid if >5 years since last dose 1, 2
• Add TIG 250 units IM if patient has not completed primary vaccination series (fewer than 3 doses) 2
• Use separate syringes and separate injection sites when giving both toxoid and TIG concurrently 1, 2

For patients with unknown or uncertain vaccination history:

• Treat as unvaccinated and provide both tetanus toxoid and TIG for tetanus-prone wounds 2
• This is particularly important for elderly patients and immigrants from regions other than North America or Europe 2

Vaccine Selection by Age

• Adults ≥7 years: Use Tdap (tetanus, diphtheria, acellular pertussis) if not previously given; otherwise use Td 5, 2
• Children <7 years: Use DTaP (diphtheria, tetanus, pertussis) 2
• Tdap is preferred over Td for the first adult booster to provide pertussis protection 5

Common Pitfall to Avoid

Do not close puncture wounds or wounds of the hand primarily, as this increases infection risk; facial wounds may be closed after copious irrigation, cautious debridement, and preemptive antibiotics 5. Other wounds may be approximated but not primarily closed 5.

---

Post-Recovery and Primary Immunization

Tetanus infection does NOT confer natural immunity; patients must complete a full primary immunization series after recovery from tetanus. 1

Primary Series for Previously Unvaccinated Adults

• First dose: Tdap (preferred over Td) 1
• Second dose: Td or Tdap at least 4 weeks after first dose 1
• Third dose: Td or Tdap 6-12 months after second dose 1
• Booster doses: Every 10 years thereafter 2

Documentation and Follow-Up

• Ensure complete documentation of tetanus vaccination status for future wound management 1
• Educate patients about the importance of maintaining immunity with decennial boosters 2
• Complete the primary series for any patient with inadequate vaccination history 2